N. Swarbrick

发表

Diagnosis of Pulmonary Hamartoma by Fine Needle Biopsy

B. Wood, F. Frost, N. Swarbrick, 2008, Acta Cytologica.

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial pro

I. Davis, A. Redfern, Dickon Hayne, 2021, BJU international.

Cutaneous ciliated cyst of the scrotum.

B. Wood, N. Harvey, N. Swarbrick, 2015, Pathology.

Sub-urothelial durvalumab injection-1 (SUBDUE-1): A novel approach to immunotherapy for bladder cancer.

I. Davis, A. Redfern, P. Viswambaram, 2021 .

Adenocarcinoma of the urethra: A rare subtype of urethral cancer

Oliver Oey, P. Viswambaram, Dickon Hayne, 2021, Urology case reports.

Diagnosis of extramammary malignancy metastatic to the breast by fine needle biopsy

G. Sterrett, B. Wood, F. Frost, 2008, Pathology.

Unique case of IgG4-related disease of the renal pelvis involving the inferior vena cava masquerading as locally advanced urothelial cancer

S. McCombie, D. Hayne, N. Swarbrick, 2022, BMJ Case Reports.

Lymph node assessment technique matters in radical cystectomy for bladder cancer

C. Hawks, P. Viswambaram, S. McCombie, 2023, ANZ journal of surgery.

Is fertility-sparing treatment for high grade cervical dysplasia conservative enough?

I. Zardawi, S. Braye, N. Swarbrick, 2008, Pathology.

Interobserver variability in the diagnosis of circumscribed sebaceous neoplasms of the skin

C. Budgeon, B. Wood, T. Beer, 2013, Pathology.

Relationship between lower urinary tract symptoms (LUTS) and prostate cancer: A persistent myth

C. Hawks, Matthew Brown, S. McCombie, 2023, Journal of Clinical Urology.

SUB-urothelial durvalumab injection: 1 (SUBDUE-1)—Results from the first nine urothelial cancer patients using a dose-escalation schedule.

I. Davis, A. Redfern, C. Hawks, 2022, Journal of Clinical Oncology.